Your browser doesn't support javascript.
loading
Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2, in patients with chronic kidney disease: A randomized trial.
He, YanLing; Pachori, Alok; Chen, Ping; Ma, Shenglin; Mendonza, Anisha E; Amer, Ahmed; Marbury, Thomas C; Hinder, Markus.
Affiliation
  • He Y; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Pachori A; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Chen P; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Ma S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Mendonza AE; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
  • Amer A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Marbury TC; Orlando Clinical Research Center, Orlando, Florida, USA.
  • Hinder M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Diabetes Obes Metab ; 23(5): 1182-1190, 2021 05.
Article in En | MEDLINE | ID: mdl-33512754
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2021 Type: Article Affiliation country: United States